ExpreS2ion is mentioned in Ingeniøren
Read full article here: https://ing.dk/artikel/danskere-vil-dyrke-coronavaccine-bananflueceller-232322
ExpreS2ion is mentioned in Nigerian Guardian
Read full article here: https://guardian.ng/interview/drug-shortage-imminent-if-coronavirus-epidemic-persists/
ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7
ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]
Upcoming Webinar: Developing an anti-HER2 breast cancer vaccine using advantageous Drosophila S2 cell protein expression and virus-like -particle display technologies
ExpreS2ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT […]
Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen
Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]
Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry
ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]
ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania
Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry
Expres2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “Biotekselskab og […]
The Francis Crick Institute Renews the Research License Agreement with ExpreS2ion Biotechnologies
Horsholm, Denmark, June 26, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]
ExpreS2ion’s Chief Science Officer, Dr. Wian De Jongh, to Speak at World Biopharm Forum 2017 in Oxford, UK – June 27
Horsholm, Denmark, June 21, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]